In our previous study, it was demonstrated that these agents retain high efficacy against MDR leukaemia HL60/VINC and HL60/DOX cells overexpressing ABC drug efflux transporters (P-gp and MRP1, respectively) [23]. This evidence concerns the gene ABCC1 and leukemia.